Pancreatic cancer advances have been making recent news, largely through the revolution that is personalized medicine, specifically immunotherapy. The statistics on pancreatic cancer are grim. Almost 50,000 people will be diagnosed in the US this year, with more than 40,000 dying from the disease. There exists no effective screening method. The disease is asymptomatic early on and spreads rapidly to other organs.